NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/27/2025
Back to search
Official data from USPTO
ENDARI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/27/2025
Trademark type
Word
Nice classes
5
Filing date
02/16/2017
Registration date
02/12/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2025
Last transaction
01/27/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/24/2018
First use in commerce
01/24/2018
Drawing code
4
Owner type
03
Owner location
Torrance, CA
Examiner
COLLIER, DAVID
Current location
Historical data usage
Holders and representatives
Holders
Emmaus Medical, Inc.
Representatives
Nicole Kinsley, Esq. FOLEY HOAG LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hematological conditionsdiseasesdisorderssickle cell disease; pharmaceutical preparations for the treatment of gastrointestinalmetabolicdiabetic conditionsdiseasesdisorders; nutraceuticals for use as a dietary supplement
Publications
History of USPTO decisions and trademark events.
26 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/27/2025
E815
TEAS SECTION 8 & 15 RECEIVED
09/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/05/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/04/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/23/2018
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/22/2018
IUAF
USE AMENDMENT FILED
07/26/2018
EISU
TEAS STATEMENT OF USE RECEIVED
07/26/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/23/2018
EX1G
SOU EXTENSION 1 GRANTED
02/21/2018
EXT1
SOU EXTENSION 1 FILED
02/21/2018
EEXT
SOU TEAS EXTENSION RECEIVED
02/21/2018
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/15/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/22/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2017
PUBO
PUBLISHED FOR OPPOSITION
06/27/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2017
DOCK
ASSIGNED TO EXAMINER
05/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2017
NWAP
NEW APPLICATION ENTERED
02/20/2017
Continuous trademark protection
Get notified about every new filing that threatens ENDARI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.